UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549


                            FORM 10-Q

   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
October 31, 1999                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At  October  31, 1999, 22,176,534 shares of common stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                 Quarter Ended October 31, 1999


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statements of Earnings for the three months
           ended October 31, 1999 and 1998                   2

           Statements of Earnings for the six months
           ended October 31, 1999 and 1998                   3

           Balance Sheets at October 31, 1999 and
           April 30, 1999                                  4-5

           Statements of Cash Flows for the six months
           ended October 31, 1999 and 1998                   6

           Notes to Financial Statements                     7

           Independent Accountants' Report                  11

  Item 2. Management's Discussion and Analysis of
          Financial Condition and Results of Operations     12

  Item 3. Quantitative and Qualitative Disclosures
          About Market Risk                                 19


Part II - Other Information

  Item 4. Submission of Matters to a Vote of Security
          Holders                                           20

  Item 5. Other Information                                 20

  Item 6.  Exhibits and Reports on Form 8-K                 21


Signature                                                   22

Exhibit Index                                               23


<PAGE 2>

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                          Three Months Ended
In thousands (except per share amounts)       October 31,
--------------------------------------- ----------------------
                                           1999        1998
                                        ---------    ---------
Revenue:

  Product sales                         $139,598     $137,992
  Service                                 13,255       12,598
                                        --------     --------
                                         152,853      150,590
                                        --------     --------

Costs and Expenses:

  Cost of product sales                   82,412       81,269
  Cost of service                          7,188        7,333
  Selling, general and administrative     38,442       37,446
  Research and development expenses        8,304        7,645
  Goodwill amortization                    2,114        2,147
                                        --------     --------
                                         138,460      135,840
                                        --------     --------

Operating income                          14,393       14,750

Other income                                 744          937
Interest expense                          (2,407)      (3,352)
                                        --------     --------

Earnings before income taxes              12,730       12,335

Provision for income taxes                 4,400        4,600
                                        --------     --------
Net earnings                            $  8,330     $  7,735
                                        ========     ========
Per share of common stock:
  Basic                                 $    .38     $    .34
  Diluted                               $    .37     $    .33

  Dividends                             $    .08     $    .08

Average shares outstanding:
  Basic                                   22,175       22,789
  Diluted                                 22,474       23,487

                     See Accompanying Notes

<PAGE 3>


            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS

--------------------------------------------------------------
                                            Six Months Ended
In thousands (except per share amounts)       October 31,
--------------------------------------- ----------------------
                                           1999        1998
                                        ---------    ---------
Revenue:

  Product sales                         $265,454     $280,158
  Service                                 26,875       24,091
                                        --------     --------
                                         292,329      304,249
                                        --------     --------

Costs and Expenses:

  Cost of product sales                  155,033      165,137
  Cost of service                         14,493       14,020
  Selling, general and administrative     73,534       77,038
  Research and development expenses       16,902       15,273
  Goodwill amortization                    4,250        4,311
                                        --------     --------
                                         264,212      275,779
                                        --------     --------

Operating income                          28,117       28,470

Other income                               1,137        1,197
Interest expense                          (4,871)      (6,510)
                                        --------     --------

Earnings before income taxes              24,383       23,157

Provision for income taxes                 8,500        8,700
                                        --------     --------
Net earnings                            $ 15,883     $ 14,457
                                        ========     ========
Per share of common stock:
  Basic                                 $    .72     $    .64
  Diluted                               $    .71     $    .62

  Dividends                             $    .16     $    .16

Average shares outstanding:
  Basic                                   22,147       22,731
  Diluted                                 22,463       23,500

                     See Accompanying Notes

<PAGE 4-5>

             GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS


---------------------------------------------------------------
                                         October 31,  April 30,
In thousands                               1999         1999
--------------------------------------   ----------  ----------
Assets
Current Assets:
 Cash and short-term cash investments     $ 20,218     $ 26,523
 Accounts receivable                       120,455      103,118
 Inventories                                92,775       72,367
 Prepaid expenses                           20,611       23,690
                                          --------     --------
                                           254,059      225,698
                                          --------     --------
Property, Plant and Equipment              158,377      152,374
 Less accumulated depreciation              61,493       61,789
                                          --------     --------
                                            96,884       90,585
                                          --------     --------

Intangible Assets                          243,278      238,777
 Less accumulated amortization              22,467       18,018
                                          --------     --------
                                           220,811      220,759
                                          --------     --------
Other Assets                                 4,651        5,218
                                          --------     --------
                                          $576,405     $542,260
                                          ========     ========
Liabilities and Shareholders' Equity

Current Liabilities:
 Current maturities of long-term debt     $     --     $    193
 Accounts payable                           57,863       48,374
 Accrued compensation and benefits          16,976       18,982
 Other accrued liabilities                  34,408       35,854
 Deferred revenue                            8,367        6,874
 Advances on sales contracts                 3,430        5,721
                                          --------     --------
                                           121,044      115,998
                                          --------     --------
Noncurrent Liabilities:
 Deferred income taxes                      10,315        9,593
 Long-term debt                            188,833      173,338
                                          --------     --------
                                           199,148      182,931
                                          --------     --------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares; no
  shares issued                                 --           --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares; issued
  22,976,534 and 22,858,699 shares          22,977       22,859
 Paid-in capital                            42,390       40,255
 Retained earnings                         208,188      195,871
 Treasury stock, at cost (800,000
  shares)                                  (16,450)     (16,450)
 Unamortized value of restricted stock
  grants                                      (457)        (417)
 Accumulated other comprehensive income
  (loss)                                      (435)       1,213
                                          --------     --------
                                           256,213      243,331
                                          --------     --------
                                          $576,405     $542,260
                                          ========     ========


                     See Accompanying Notes

<PAGE 6>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF CASH FLOWS
----------------------------------------------------------------------
                                                  Six Months Ended
In thousands                                         October 31,
--------------------------------------------    ----------------------
                                                  1999         1998
                                               ----------   ---------
Cash Provided by (Used for):
Operating Activities:
  Net earnings                                  $ 15,883    $  14,457
  Adjustments to reconcile net earnings to
   cash provided by operating activities:
     Depreciation and amortization                12,359       10,729
     Deferred income taxes                           722         (210)
     Other non-cash items                            155          122
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                (15,024)     (13,738)
      Inventories                                (15,691)       8,162
      Prepaid expenses                             3,079       11,096
      Accounts payable and accrued expenses        2,580       (2,836)
                                                --------     --------
Provided by Operating Activities                   4,063       27,782
                                                --------     --------
Investing Activities:
  Additions to property, plant and equipment     (13,251)      (7,010)
  Business acquisitions                           (7,452)    (175,952)
  Intangible and other assets                       (340)         362
  Other, net                                        (391)       1,923
                                                --------     --------
(Used for) Investing Activities                  (21,434)    (180,677)
                                                --------     --------
Financing Activities:
  Additions of long-term debt                     30,274      181,686
  Repayments of long-term debt                   (16,229)     (19,648)
  Net short-term financing                        (1,249)     (11,963)
  Debt issue costs                                    --         (800)
  Proceeds from issuance of stock                  1,809        2,025
  Dividends on common stock                       (3,539)      (3,632)
                                                --------     --------
Provided by Financing Activities                  11,066      147,668
                                                --------     --------

(Decrease) in Cash and Short-Term
  Cash Investments                                (6,305)      (5,227)

Cash and Short-Term Cash Investments,
  Beginning of Period                             26,523       27,007
                                                --------     --------
Cash and Short-Term Cash Investments,           $ 20,218     $ 21,780
  End of Period                                 ========     ========

                     See Accompanying Notes

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
     NOTES TO (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. Basis of Presentation

The accompanying unaudited consolidated financial statements have
been  prepared  in accordance with generally accepted  accounting
principles  for  interim  financial  statements  and   with   the
instructions  to  Form  10-Q and Article 10  of  Regulation  S-X.
Accordingly,  they  do  not include all of  the  information  and
footnotes  required  by generally accepted accounting  principles
for complete financial statements.  In the opinion of management,
all   adjustments  (consisting  of  normal  recurring   accruals)
considered necessary for a fair presentation have been  included.
Operating  results  for  the three- and six-month  periods  ended
October  31,  1999 are not necessarily indicative of the  results
that may be expected for the year ended April 30, 2000.

For  further  information,  refer to the  consolidated  financial
statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 1999.

NOTE 2. Inventories

The classification of inventories was as follows (in thousands):

                                October 31, 1999  April 30, 1999
                                ----------------  --------------
Raw materials & purchased parts    $53,949            $42,097
Work in process                     38,826             30,270
                                   -------            -------
                                   $92,775            $72,367
                                   =======            =======

NOTE 3. Segment Information

                         Three Months Ended   Six Months Ended
In thousands                October 31,          October 31,
-----------------------  -----------------   -------------------
                           1999      1998      1999      1998
                         --------  --------  --------- ---------
Segment revenue:
 Sign Making &
  Specialty Graphics     $ 72,993  $ 71,240   $141,327  $143,799
 Apparel & Flexible
  Materials                56,607    53,434    105,472   106,702
 Ophthalmic Lens
  Processing               23,253    25,916     45,530    53,748
                         --------  --------   --------  --------
                         $152,853  $150,590   $292,329  $304,249
                         ========  ========   ========  ========

<PAGE 8>

Segment profit:
 Sign Making &
  Specialty Graphics     $  8,782  $  9,027   $ 17,648  $ 18,107
 Apparel & Flexible
  Materials                 6,607     6,960     11,751    12,481
 Ophthalmic Lens
  Processing                1,416     1,624      2,667     3,283
                         --------  --------   --------  --------
                         $ 16,805  $ 17,611   $ 32,066  $ 33,871
                         ========  ========   ========  ========

A  reconciliation  of  total  segment  profits  to  consolidated
earnings before income taxes is as follows:

                         Three Months Ended    Six Months Ended
In thousands                 October 31,         October 31,
------------------------ ------------------    ----------------
                           1999       1998      1999      1998
                         --------   --------  -------   --------
Segment profit            $ 16,805  $ 17,611  $ 32,066  $ 33,871
Corporate expenses, net
 of other income/expense    (1,668)   (1,924)   (2,812)   (4,204)
                          --------  --------  --------  --------
Earnings before interest
 and taxes                  15,137    15,687    29,254    29,667
Interest expense            (2,407)   (3,352)   (4,871)   (6,510)
                          --------   --------  --------  --------
Earnings before income
 taxes                    $ 12,730  $ 12,335  $ 24,383  $ 23,157
                          ========  ========  ========  ========

There  were no material changes in segment assets or differences
in  the  basis of segmentation since the Company's  last  Annual
Report on Form 10-K.  However, the measure of segment profit was
changed.  In the Company's segment disclosures on Form 10-K  for
the  year  ended  April  30,  1999,  an  allocation  of  general
corporate  expenses  was  included in  the  measure  of  segment
profit.  For the three- and six-month periods ended October  31,
1999  and  1998,  segment profit is reported as earnings  before
interest, taxes, and general corporate expenses.

NOTE 4. Comprehensive Income

The Company's total comprehensive income was as follows:

                               Three Months    Six Months Ended
In thousands                Ended October 31,     October 31,
--------------------------  -----------------  ----------------
                              1999     1998     1999      1998
                            -------  --------  -------   -------
Net earnings                 $ 8,330  $ 7,735  $15,883   $14,457
Other comprehensive income
 (loss):
  Foreign currency
   translation adjustments    (1,083)  (2,445)  (1,648)   (1,835)
                             -------  -------  -------   -------
  Total comprehensive
   income                    $ 7,247  $ 5,290  $14,235   $12,622
                             =======  =======  =======   =======

<PAGE 9>

NOTE 5. Earnings Per Share

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share for the periods indicated:

                           Three Months Ended        Six Months Ended
                               October 31,              October 31,
                         -----------------------  -----------------------
                            1999        1998          1999        1998
                         ----------  ----------   ----------- -----------
Numerator:
 Net Income              $ 8,330,000 $ 7,735,000  $15,883,000 $14,457,000
                         =========== ===========  =========== ===========
Denominators:
 Denominator for
  basic earnings per
  share--weighted-
  average shares
  outstanding             22,175,402  22,789,437   22,146,571  22,731,381
 Effect of dilutive
  securities:
  Employee stock
   options                   298,299     697,116      316,040     769,047
                         -----------  ----------  ----------- -----------
  Denominator for
   diluted earnings
   per share--adjusted
   weighted-average
   shares outstanding     22,473,701  23,486,553   22,462,611  23,500,428
                         ===========  ==========  =========== ===========
Basic earnings per
 share                   $       .38 $       .34  $       .72 $       .64
                         =========== ===========  =========== ===========
Diluted earnings per
 share                   $       .37 $       .33  $       .71 $       .62
                         =========== ===========  =========== ===========

<PAGE 10>

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES




With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at October 31,  1999
and  for the three- and six-month periods ended October 31,  1999
and 1998, KPMG LLP has made a review (based on procedures adopted
by  the  American Institute of Certified Public Accountants)  and
not  an  audit,  as  set  forth in their  separate  report  dated
November  17,  1999 appearing on page 11.  That report  does  not
express   an   opinion  on  the  interim  unaudited  consolidated
financial  information.   KPMG  LLP  has  not  carried  out   any
significant  or additional audit tests beyond those  which  would
have  been  necessary  if  their report had  not  been  included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.


<PAGE 11>

                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
six-month   periods  ended  October  31,  1999  and   1998,   the
consolidated  statements of cash flows for the six-month  periods
ended  October  31,  1999 and 1998, and the consolidated  balance
sheet  as  of  October  31,  1999 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
generally   accepted  auditing  standards,  and   expressed   our
unqualified  opinion  dated May 26,   1999  on  the  consolidated
financial  statements  for the year ended  April  30,  1999  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and  six-month
periods  ended  October  31,  1999  and  1998,  the  consolidated
statements of cash flows for the six-month periods ended  October
31,  1999  and  1998,  or the consolidated balance  sheet  as  of
October  31,  1999  for them to be in conformity  with  generally
accepted   accounting  principles.  Also,  in  our  opinion   the
information in the accompanying consolidated balance sheet as  of
April 30, 1999 is fairly presented, in all material respects,  in
relation to the consolidated balance sheet from which it has been
derived.




/s/ KPMG LLP


Hartford, Connecticut
November 17, 1999

<PAGE 12>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

In September 1999, the Company purchased the assets of Graphi-cal
Group with cash.  Accordingly, Graphi-cal was included in  the
Company's balance sheet at October 31, 1999, in the Company's results
from operations for the three- and six-month periods ended October 31,
1999,  and  in the Company's cash flows for the six-month  period
ended October 31, 1999.

In  this  year's second quarter, the Company started  to  display
goodwill amortization as a separate line item in its consolidated
statements of earnings.  All prior periods affected by the change
have  been  restated. This accounting change represents  a  first
step  in  complying  with  the  disclosure  requirements  of  the
Financial  Accounting  Standards  Board's  (FASB's)  proposal  on
business combinations and facilitates the calculation of earnings
before goodwill amortization.

Sales for the three- and six-month periods ended October 31, 1999
were  $152.9  million  and  $292.3 million,  respectively.   This
year's second quarter sales increased 1.5 percent over the  prior
year  while year-to-date sales decreased 3.9 percent. Both second
quarter  and  year-to-date  sales  were  adversely  affected   by
relatively  weaker  European currencies this  year.   Anticipated
lower  shipments  in  the  Company's Ophthalmic  Lens  Processing
operating  segment  also accounted for part of  the  year-to-date
sales decrease.  This year's second quarter sales rebounded  from
the  first  quarter  impact  of  implementing  a  new  enterprise
resource planning (ERP) system.

The  Company's  backlog grew significantly in this year's  second
quarter  to  $66.8 million at October 31, 1999,  an  increase  of
$18.5  million  from the prior year comparable period  and  $16.0
million higher than at the beginning of the current fiscal  year.
This  growth  was  caused by higher levels  of  orders  received,
particularly for products recently introduced, and some  shipment
delays.

Operating  income  for  the three- and  six-month  periods  ended
October   31,   1999   of  $14.4  million  and   $28.1   million,
respectively,  were  substantially the same  as  the  prior  year
comparable  periods  of  $14.7 million and  $28.5  million.   The
Company's  gross  profit margin of 41.4 percent  in  this  year's
second  quarter  was substantially the same  as  the  prior  year
margin  of  41.2 percent.  Higher research and development  (R&D)
spending, particularly related to this year's strong new  product
flow,  contributed to this year's lower second quarter  operating
profit of 9.4 percent compared with the prior year margin of  9.8
percent.

For  the  six-month period ended October 31, 1999, the  Company's
gross  profit  margin of 42.0 percent was 0.9  percentage  points

<PAGE 13>

higher  than  the prior year comparable margin of  41.1  percent.
This was caused by a sales mix in this year's first quarter which
favored  higher  margin  products as well  as  higher  levels  of
service revenue.  Lower first quarter S,G,&A spending resulted in
an  operating profit margin of 9.6 percent in the first  half  of
this  year, which was 0.2 percentage points higher than the prior
year  comparable  period margin of 9.4 percent.   The  effect  of
acquisition synergies and actions taken to resize the  Ophthalmic
Lens  Processing operating segment in last year's fourth  quarter
contributed to the margin improvement.

Lower  interest expense and a lower tax rate caused net  earnings
to  rise  for the three- and six-month periods ended October  31,
1999  compared with the same periods last year. Diluted  earnings
per  share increased 12.1 percent to $0.37 in this year's  second
quarter and 14.5 percent to $0.71 in this year's first half  from
$0.33  per share and $0.62 per share, respectively, for the  same
periods last year.

The  Company's  cash flow was adversely affected in  this  year's
first half by growth in working capital.  This growth was related
to  increased inventory associated with the introduction  of  new
products  and inventory and receivable build-ups related  to  the
first quarter ERP system implementation noted above.


FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.1  to 1 at October 31, 1999 compared with 1.9 to 1 at April 30,
1999.   Net  working  capital  at October  31,  1999  was  $133.0
million, an increase of $23.3 million from the beginning  of  the
current  fiscal year and largely attributable to higher  accounts
receivable  and  inventory  levels.  The  increase  in   accounts
receivable balances was primarily caused by the higher volume  of
second quarter shipments and the acquisition of Graphi-cal.  The
increase  in inventory balances was largely attributable  to  the
rising  backlog  of  new  products recently  introduced  and  the
acquisition   of   Graphi-cal.   Although  most   of   the   ERP
implementation  issues  that arose  in  the  first  quarter  were
resolved,   both  inventory  and  accounts  receivable   balances
continued  to  be affected in the second quarter.   Reduction  of
inventory  and  receivable balances represent a significant  cash
flow generation opportunity for the Company.

The  Company's  cash  and investments totaled  $20.2  million  at
October  31, 1999 compared with $26.5 million at the end  of  the
prior fiscal year.  Operating activities provided $4.1 million in
cash  for  the  six-month period ended October 31, 1999  compared
with  $27.8 million provided by operating activities for the same
period  last  year. Cash generated by earnings and  the  non-cash
charges  for  depreciation and amortization in this year's  first
six months was offset by higher accounts receivable and inventory
balances, as discussed above. Higher accounts payable and accrued

<PAGE 14>

liabilities balances, due largely to the timing of payments, also
contributed to the cash generation in the first six months.

The  principal non-operating uses of cash in the six months ended
October  31,  1999  were for additions to  property,  plant,  and
equipment of $13.3 million and the acquisition of Graphi-cal  of
$8.7  million, which included repayment of its debt.  The Company
anticipates that capital expenditures for the current fiscal year
will  be  in the range of $23 - $24 million.  Cash was also  used
for payment of dividends of $3.5 million in the first six months.

The Company's total long-term debt at October 31, 1999 was $188.8
million,  which  was higher than the April 30,  1999  balance  of
$173.5  million. Net debt (total debt less cash and  investments)
was  $168.6 million at October 31, 1999 versus $147.0 million  at
April 30, 1999, as cash was required in the first six months  for
acquisition funding and to finance the growth in inventories  and
accounts  receivable.   The ratio of net debt  to  total  capital
increased  to 39.7 percent at October 31, 1999 from 37.7  percent
at April 30, 1999.

RESULTS OF OPERATIONS

Combined  sales  and  service revenue for the three-month  period
ended  October 31, 1999 increased $2.3 million (1.5 percent)  and
for  the six-month period ended October 31, 1999 decreased  $11.9
million (3.9 percent) from the prior year comparable periods. The
increase in the second quarter reflected higher product sales and
service  revenue.  The decrease on a year-to-date basis reflected
lower  product  sales  and higher service  revenue.   The  higher
product  sales  in  this year's second quarter came  from  higher
shipments in the Apparel and Flexible Materials operating segment
($2.7 million), largely resulting from a rebound in international
markets for that segment's products, and higher shipments in  the
Sign  Making  and  Specialty  Graphics  operating  segment  ($1.5
million),  resulting  from  the  Graphi-cal  acquisition.    The
service  revenue increase of $0.7 million (5.2 percent)  in  this
year's  second  quarter also came from these operating  segments.
The  higher  sales in these segments overcame the second  quarter
impact  of  relatively weaker foreign currencies ($3.5  million).
Product  sales  and  service  revenue  for  the  Ophthalmic  Lens
Processing  operating segment were lower in  the  second  quarter
compared   with   the  prior  year  ($2.7  million   lower),   as
anticipated.

The lower product sales in the six-month period ended October 31,
1999 were predominantly caused by anticipated lower shipments  of
Ophthalmic  Lens Processing equipment ($8.1 million);  the  prior
year first quarter sale of certain distribution operations in the
Sign  Making  and  Specialty  Graphics  operating  segment  ($2.5
million);  the  impact  on  sales of  relatively  weaker  foreign
currencies  ($6.0  million); and this year's  first  quarter  ERP
implementation  in  the Apparel and Flexible Materials  operating
segment.  The higher second quarter product sales in the  Apparel

<PAGE 15>

and  Flexible  Materials and Sign Making and  Specialty  Graphics
operating  segments noted above were an offset.  Service  revenue
increased  $2.8  million (11.6 percent) in the  six-month  period
ended  October  31,  1999.  The largest increase  came  from  the
Apparel  and Flexible Materials operating segment and was  partly
the  result of incentives used to enhance that segment's  service
business.

The consolidated gross profit margins in this year's first three-
and  six-month periods ended October 31, 1999 were  41.4  percent
and  42.0 percent, respectively, which were higher than the prior
year  comparable margins of 41.2 and 41.1 percent,  respectively.
Gross  profit  margins  on both product sales  and  service  were
higher.   The  increase in product gross profit margins  was  the
result  of a product mix favoring higher margin products such  as
software in the Apparel and Flexible Materials operating  segment
and  newly introduced digital imaging products in the Sign Making
and  Specialty  Graphics  operating segment.   The  increases  in
service gross profit margins related primarily to the Apparel and
Flexible  Materials  operating segment and  were  caused  by  the
service revenue increases noted above.

Selling,  general, and administrative (S,G,&A) expenses  in  this
year's second quarter increased $1.0 million (2.7 percent) and in
this year's first six months decreased $3.5 million (4.5 percent)
from  the prior year comparable periods.  Increases in the second
quarter  came from increased marketing expenses relating  to  new
products and from including Graphi-cal's S,G,&A expenses for the
two  months ended October 31, 1999.  The S,G,&A increase  in  the
quarter was partly offset by management action taken in the prior
year  to resize the Ophthalmic Lens Processing operating segment.
The decrease in the first six months compared with the prior year
was  caused by the management action noted above and by marketing
synergies  realized  by  the  Company  in  the  Sign  Making  and
Specialty  Graphics operating segment through the acquisition  of
Spandex  PLC  and  in  the Ophthalmic Lens  Processing  operating
segment  through  the  acquisition of Coburn Optical  Industries,
Inc.

After adjusting for the reclassification of goodwill amortization
mentioned earlier, S,G,&A expenses were 25.2 percent of sales  in
both  this  year's second quarter and first six  months  compared
with  24.9  percent and 25.3 percent, respectively, in the  prior
year comparable periods.

The Company continued to commit significant resources to research
and  the  development  of  new products. R&D  spending  increased
$0.7 million (8.6 percent) in the second quarter and $1.6 million
(10.7  percent) in the first six months compared with last year's
comparable  periods.  The increase was related to the  stepped-up
flow  of  new  products  from  each of  the  Company's  operating
segments.  As a percentage of sales, research and development was
5.4  percent in the second quarter and 5.8 percent in  the  first

<PAGE 16>

six   months   compared  with  5.1  percent  and   5.0   percent,
respectively, in the prior year comparable periods.

Interest expense decreased $0.9 million in the second quarter and
$1.6  million  in the first six months to $2.4 million  and  $4.9
million, respectively.  These decreases were the result of  lower
interest  rates  and,  to  a lesser extent,  lower  average  debt
balances.  Most of the Company's borrowings were against  a  $235
million  multi-currency revolving credit facility.  The  interest
rate on these borrowings is based on the London Interbank Offered
Rate  (LIBOR)  for the relevant currency and term plus  a  margin
based  on  the  relationship of the Company's consolidated  total
debt  to  EBITDA (earnings before interest, taxes,  depreciation,
and amortization).

The  provision  rate for income taxes was 34.6  percent  for  the
second quarter and 34.9 percent for the first six months compared
with  37.3 percent and 37.6 percent in the comparable prior  year
periods and 35.8 percent for the full prior year.  The lower  tax
rates  this  year  were  primarily the result  of  tax  reduction
strategies   involving   the   Company's   wholly-owned   foreign
subsidiaries.

As  a  result of the above, net earnings increased in this year's
second quarter to $8.3 million or $.37 diluted earnings per share
from  $7.7  million or $.33 diluted earnings per  share  in  last
year's  second quarter.  For the first six months,  net  earnings
this year increased to $15.9 million or $.71 diluted earnings per
share compared with $14.5 million or $.62 per diluted share  last
year.

NEW ACCOUNTING PRONOUNCEMENT

In  June  1998, the Financial Accounting Standards  Board  (FASB)
issued  Statement No. 133, "Accounting for Derivative Instruments
and  Hedging  Activities" (SFAS 133).  The Statement  establishes
accounting  and  reporting  standards requiring  that  derivative
instruments be recorded in the balance sheet as either  an  asset
or  liability  measured at fair value and that  changes  in  fair
value  be recognized currently in earnings, unless specific hedge
accounting  criteria  are met.  In June  1999,  the  FASB  issued
Statement  No.  137, "Accounting for Derivative  Instruments  and
Hedging  Activities  -  Deferral of the Effective  Date  of  FASB
Statement  No. 133," which delays the required adoption  of  SFAS
133  to  the Company's fiscal year 2002.  The timing of  adoption
and the effect of SFAS 133 on the Company's financial position or
results of operations have not yet been determined.

YEAR 2000

As  disclosed in the Company's Annual Report on Form 10-K for the
year  ended  April 30, 1999, the Company recognizes the  business
risks  posed by the Year 2000 date issue and is actively  working
to  control  the associated risks.  The risks identified  by  the

<PAGE 17>

Company's  Year 2000 compliance program remain the same  and  the
Company's  assessment  and remediation  plans  have  not  changed
materially  in terms of scope, timing, or estimated  costs.   The
Company  believes that it has completed all critical  aspects  of
its  Year  2000 readiness program.  Although the Company designed
this  program to properly prepare its systems and products for the
Year  2000, there  can  be no assurance that the Company will not
experience business  disruptions  or  incur material  costs  caused
by  the failure  to  detect   and remediate all instances  of  Year
2000 noncompliance  in its systems and products.  Contingency plans,
including those designed to prevent the failure of critical systems
from having a material effect on the Company, are nearing completion.

The  Company  continues to evaluate its risks and, as  necessary,
update  contingency plans.  Total costs to resolve the Year  2000
issue  were  not  material to the Company's  financial  position,
results of operations or cash flows.

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains statements which, to the extent
they are not statements of historical or present fact, constitute
"forward-looking  statements" under the  securities  laws.   From
time to time, oral or written forward-looking statements may also
be  included  in other materials released to the  public.   These
forward-looking  statements are intended to provide  management's
current  expectations  or  plans for  the  future  operating  and
financial  performance  of  the  Company,  based  on  assumptions
currently  believed to be valid.  Forward-looking statements  can
be  identified  by the use of words such as "believe,"  "expect,"
"plans,"    "strategy,"   "prospects,"   "estimate,"   "project,"
"anticipate,"  and other words of similar meaning  in  connection
with  a  discussion of future operating or financial performance.
These include, among others, statements relating to:

-    the  effect  of  economic downturns or growth in  particular
     regions,
-    the effect of changes in the level of activity in particular
     industries or markets,
-    the anticipated uses of cash,
-    the scope or nature of acquisition activity,
-    prospective product developments,
-    cost reduction efforts,
-    the outcome of contingencies,
-    the impact of Year 2000 conversion efforts, and
-    the transition to the use of the euro as a currency.

All  forward-looking statements involve risks  and  uncertainties
that  may  cause actual results to differ materially  from  those
expressed  or  implied  in the forward-looking  statements.   For
additional information identifying factors that may cause  actual
results  to  vary  materially from those stated in  the  forward-
looking  statements,  see the Company's reports  on  Forms  10-K,

<PAGE 18>

10-Q,  and  8-K filed with the Securities and Exchange Commission
from time to time.  The Company's Annual Report on Form 10-K  for
fiscal  year  1999  includes important  information  as  to  risk
factors  in  the "Business" section under the headings "Operating
Segments"  and  "Other  Matters  Relating  to  the  Corporation's
Business as a Whole."

<PAGE 19>

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES
         ABOUT MARKET RISK

No  material  changes  have  occurred  in  the  quantitative  and
qualitative  market risk disclosures for the Company  from  those
presented  in  the Company's Annual Report on Form 10-K  for  the
year ended April 30, 1999.

<PAGE 20>


                   PART II - OTHER INFORMATION

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On  September  15, 1999, the Company held its annual  meeting  of
shareholders.  The holders of 88 percent of the shares of  common
stock  entitled  to vote at this meeting were present  either  in
person  or  by proxy.  The following were the voting results  for
the meeting:

   -  The shareholders elected Directors to hold office until the
      annual meeting to be held in the year 2002 with the following
      votes:
                                   For            Withheld

      David J. Logan           18,473,931         982,399
      Carole F. St. Mark       19,071,490         384,840
      A. Robert Towbin         18,375,996       1,080,334

      The  terms  of  office  of the other Directors,  Donald  P.
      Aiken,  Michael  J. Cheshire, George M. Gentile,  David  J.
      Gerber,   Edward  E.  Hood,  Jr.,  and  W.  Jerome  Vereen,
      continued after the meeting.

   -  The  shareholders  approved  the Gerber   Scientific,   Inc.
      2000-2004   Executive   Annual Incentive  Bonus  Plan  with
      18,496,160  votes  in  favor, 847,543 votes against, and
      111,627 abstentions.  Votes  not cast totaled 1,000.


ITEM 5.   OTHER INFORMATION

On  September  13,  1999,  the Company  issued  a  press  release
reporting  the  acquisition  of  Graphi-cal  Group,  Australia's
largest  sign making supplies distributor with approximately  $12
million  (U.S.)  in  annual revenues.   The  purchase  price  was
approximately   $7.5  million.   In  addition,  Graphi-cal   had
approximately $1.2 million in outstanding debt that was assumed.

On November 1, 1999, the Company issued a press release reporting
the  acquisition of R&D Marketing Aktiebolag (R&D  Marketing),  a
leading Scandinavian sign making supplier distributor located  in
Sweden,  with approximately $8 million (U.S.) in annual revenues.
The purchase price was approximately $3.1 million.  R&D Marketing
will be included in the Company financial statements starting  in
this year's third quarter.

<PAGE 21>


                   PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits

     (15)*       Letter  regarding unaudited interim  financial
                 information.
     (27)*       Financial data schedule.


(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.



*Filed herewith.

<PAGE 22>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   December 9, 1999    By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)

<PAGE 23>

                          EXHIBIT INDEX





  Exhibit
   Index                                                     Page
  Number                                                     ----
 --------

   (15)*       Letter regarding unaudited interim financial
               information.
   (27)*       Financial data schedule.







*Filed herewith.